Directors of ReMedy and IMol
invite you to
the 5th International ReMedy Minisymposium
Tuesday, May 25th, 2021, 2:30 p.m. CET
(register to receive the link)
14:30 - 14:40
Prof. Agnieszka Chacińska - ReMedy Director
14:40 - 16:10
Chair: Dr. Piotr Szwedziak
Dr. Abdelhalim Azzi,
CBRC, MGH-Harvard Medical School, USA
“Role of phosphoinositide kinases and phosphatases in circadian physiology”
Dr. Jarosław Cendrowski,
Laboratory of Cell Biology International Institute of Molecular and Cell Biology, Warsaw, Poland
“Membrane trafficking during erythroid differentiation in normal erythropoiesis or upon stress”
Dr. Maciej Cieśla,
Lund Stem Cell Center, Lund University, Sweden
"Beyond the post-genomic era. Post-transcriptional gene regulatory networks in stem cells and cancer"
16:10 - 16:20
16:20 - 17:20
Chair Dr. Anna Marusiak
Dr. Bartłomiej Blus,
BioMarin Pharmaceutical Inc., USA
"Intrinsic protein disorder in macromolecular interactions within the cell nucleus"
Dr. Michał Barski,
St Mary’s Hospital, Imperial College London, UK
“From viral molecular mimicry and retrotransposition to cancer"
Closing of the Symposium
The „Regenerative Mechanisms for Health” International Research Agenda Unit (“ReMedy”) is a joint unit of the University of Warsaw and University Medical Center Göttingen at Georg-August-University Göttingen, funded by a grant by the Foundation for Polish Science. The goal of ReMedy is to understand and to harness stress‐evoked adaptability of cells at the molecular and biochemical level, in order to combat human diseases and pathologies.
ReMedy is funded by Foundation for Polish Science International Research Agendas Programme (project MAB/2017/2) under measure 4.3 "International Research Agendas“, Smart Growth Operational Programme 2014-2020. Financial support: 35 738 870 PLN (100% contribution of European Funds).
PLEASE NOTE: Unfortunately due to technical restrictions we had to limit the number of participants.
Please register using the below form.
A link to the seminar will be sent to your e-mail address